Abstract:There has been growing clinical evidence of the value of targeted alpha therapy for treatment of several cancers. The work has been slowed by the lack of availability of the key alpha emitting isotopes, especially Ac-225. Until this time, most of the supply has been from three Th-229 generators that are milked to produce hundreds of mCi of Ac-225 every month. There has been a growing effort to produce new sources of Ac-225 from several different accelerator-based routes. It can be produced with medical-isotope cyclotrons with a proton energy of at least 16 MeV using the reaction Ra-226(p,2n)Ac-225. It can also be produced by using high-energy protons (150 to 800 MeV) for spallation of a thorium target. Significant experimental work has been applied to both processes. It can also be produced by the photonuclear reaction, Ra-226({\gamma},n)Ra-225. The Ra-225 decays via beta decay to Ac-225 with a half life of 14.9 days. The photons are produced by an intense beam of electrons with an energy about 25 to 30 MeV. This paper will provide a technical description of radium targets and a target chamber that would be capable of producing a yield of four curies of Ra-225 from a 10-day irradiation of one gram of radium segmented into two to four separate encapsulated targets, at a beam power of 20 kW. These targets could be milked at least three times, yielding nearly four curies of Ac-225. There is also a description of a method to reduce production of Ac-227 to values less than a few parts per million of the yield of Ac-225. The Monte Carlo code Fluka has been used to model the yields of Ra-225 and support the design concept to reduce the production of Ac-227. It has also been used to model the experimental results by Maslov et al. [<a class="link-external link-https" href="https://doi.org/10.1134/S1066362206020184" rel="external noopener nofollow">this https URL</a>] to provide reasonable confidence in the cross-section value used by the code.

226Ra irradiation to produce 225Ac and 213Bi in an accelerator-driven system reactor

Semi-Permanent Mass Production of Ac-225 for Cancer Therapy by the (3n,x) Reaction in Pressurized Water Reactor

Effect of 226Ra purity as a target for 225Ac production using a fast reactor

225Ac production via 226Ra (μ−, n ν) 225Fr reaction with 226Ra target

Potential production of Ac-225 at Egyptian second research reactor (ETRR-2) through neutron induced transmutation of Ra-226

Actinium-225 photonuclear production in nuclear reactors using a mixed radium-226 and gadolinium-157 target

A new method in the production of Ac-227, Ra-228, Th-228 and U-232 on Thorium target from different perspective for use in Radioisotope Power Systems and Nuclear Batteries

Actinium-225 Production with an Electron Accelerator

Extraction generator of 223Ra for nuclear medicine

Enhanced transmutation of minor actinides by incorporation of multi-beam design in Accelerator-Driven subcritical system

Nuclear Transmutation of 99Tc Utilizing Proton Spallation and Compact Subcritical Assembly

Possibility assessment for production of non-traditional nuclear fuel in thorium blanket of hybrid thermonuclear reactor

Neutron-Physical and Radiation Characteristics of Different Low Enrichment Fuels (Thorium and Uranium) in a Proposed JRTR Research Reactor

An electrochemical generator for the continual supply of 213Bi from 225Ac for use in targeted alpha therapy applications

Calculations of neutron fluxes and isotope conversion rates in a thorium-fuelled MYRRHA reactor, using GEANT4 and MCNPX, Nuclear Engineering and Design

Physical Scheme Study of 10 MW Accelerator Driven Sub-critical Reactor

Preliminary Study on Transmutation of Plutonium and Minor Actinides in Accelerator Driven System

Radium separation from thorium and manufacturing of targets by precipitation method

Study Analysis of Multiplication Factor on ADS Transmutation System

Method and mechanism for efficient radium isolation from bulk thorium based on anion exchange

Status of the 226Ra nuclear data library and its impact on the production amount of 225Ac via the 226Ra (n,2n) reaction